Koers Critical Outcome Technologies Inc. Toronto S.E.
Aandelen
COT
CA22675B1031
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- CAD | - |
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 1,61 mln. 2,2 mln. 1,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -4 mln. -5,47 mln. -3,74 mln. | Nettowinst (verlies) 2019 | -2 mln. -2,73 mln. -1,87 mln. | EV/omzet 2018 | - |
Nettoliquiditeiten 2018 | 40,73K 55,68K 38,09K | Nettoliquiditeiten 2019 | 24,64K 33,68K 23,05K | EV/omzet 2019 | - |
K/w-verhouding 2018 |
-1,11
x | K/w-verhouding 2019 |
-0,6
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 69,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01-01-15 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12-06-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-07-18 | |
John C. Drake
CHM | Chairman | - | 20-02-07 |
Alison D. Silva
PSD | President | 46 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers COTQF
- Koers COT